-
HEALTHCARE RESOURCE UTILIZATION AND ECONOMIC BURDEN BY COMORBIDITY STATUS IN IDIOPATHIC PULMONARY FIBROSIS: A US REAL-WORLD CLAIMS STUDY
Aug 11, 2026, 17:15 PM -
COMPARATIVE EFFECTIVENESS AND SAFETY OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITORS VERSUS ACEI/ARB THERAPY IN HEART FAILURE: A REAL-WORLD RETROSPECTIVE COHORT STUDY
Aug 11, 2026, 17:15 PM -
DEVELOPMENT OF A PAN-EUROPEAN PREFERENCE SURVEY IN CYSTIC FIBROSIS: QUANTIFYING PREFERENCES ON CLINICAL ENDPOINTS, GENE THERAPY AND ORGANOIDS
Aug 11, 2026, 17:15 PM -
COST-EFFECTIVENESS OF ROUTINE MENTAL HEALTH SCREENING IN INFLAMMATORY ARTHRITIS RHEUMATOLOGY: A DISCRETE EVENT SIMULATION OF THE IMPARTS PROGRAM
Aug 11, 2026, 17:15 PM -
INTERCOUNTRY COMPARISON OF THE REAL WORLD DATA ACCESSIBILITY IN ASIA AND BEYOND: PROGRESS AND CHALLENGES
Aug 11, 2026, 17:15 PM -
ECONOMIC AND HUMANISTIC BURDEN OF COMPENSATED METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) CIRRHOSIS: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:15 PM -
PENILE CANCER CARE IN BRAZIL: NATIONAL PATTERNS OF OUTPATIENT AND INPATIENT SERVICE USE
Aug 11, 2026, 17:15 PM -
FROM OPTIONAL TO EXPECTED? A CROSS-COUNTRY REVIEW OF BROADER VALUE EVIDENCE IN EUROPEAN HTA METHODS GUIDANCE
Aug 11, 2026, 17:15 PM -
METHODOLOGICAL APPROACHES TO HEALTH ECONOMIC EVALUATIONS OF PREP STRATEGIES: A LITERATURE REVIEW
Aug 11, 2026, 17:15 PM -
EVALUATING THE ECONOMIC IMPACT OF EARLIER CAR T USE IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A 24-MONTH COST SEQUENCING ANALYSIS FROM THE BRAZILIAN PRIVATE HEALTHCARE PERSPECTIVE
Aug 11, 2026, 17:15 PM -
GREY AREAS: DOES GREY LITERATURE BELONG IN EVERY SLR?
Aug 11, 2026, 17:15 PM -
THE IMPACT OF A COMMUNITY HEALTH WORKER INTERVENTION VERSUS USUAL CARE ON HEALTHCARE UTILIZATION AMONG PEOPLE WITH UNMET HEALTH NEEDS IN BELGIUM: A MIXED METHODS STUDY
Aug 11, 2026, 17:15 PM -
ECONOMIC IMPACT OF SWITCHING TO ACELLULAR PERTUSSIS HEXAVALENT VACCINES FROM CURRENT WHOLE-CELL BASED VACCINATION PROGRAMS: A TARGETED LITERATURE REVIEW
Aug 11, 2026, 17:15 PM -
EVALUATING THE ROBUSTNESS OF TIME-TO-EVENT ANALYSES IN DE-IDENTIFIED REAL-WORLD DATASET USING A PROXY DATE OF DEATH ALGORITHM: A VALIDATION STUDY IN PATIENTS WITH MULTIPLE MYELOMA
Aug 11, 2026, 17:15 PM -
UPDATED COST-EFFECTIVENESS OF LECANEMAB IN EARLY ALZHEIMER'S DISEASE: A CANADIAN SOCIETAL PERSPECTIVE
Aug 11, 2026, 17:15 PM -
ECONOMIC BURDEN AND HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH CEMIPLIMAB-RELATED ADVERSE DRUG REACTIONS IN BRAZIL: EVIDENCE FROM A NATIONAL PHARMACOVIGILANCE DATABASE
Aug 11, 2026, 17:15 PM -
PATIENT INVOLVEMENT IN EUROPEAN HEALTH TECHNOLOGY ASSESSMENT: A SYSTEMATIC REVIEW WITH RECOMMENDATIONS FOR BELGIUM
Aug 11, 2026, 17:15 PM -
REIMBURSEMENT CHALLENGES AND INNOVATIVE PAYMENT MODELS FOR ADVANCED THERAPY MEDICINAL PRODUCTS: A SCOPING REVIEW
Aug 11, 2026, 17:15 PM -
PROMPT SPECIFICATION AND EXPERT OVERSIGHT SHAPE AI-ASSISTED LITERATURE REVIEW OUTPUTS ACROSS DISEASE AREAS
Aug 11, 2026, 17:15 PM -
IMPROVING EFFICIENCY OF MODEL PARAMETERISATION WITH AN ARTIFICIAL INTELLIGENCE INDEXING TOOL
Aug 11, 2026, 17:15 PM
